21 March 2023
ANDROMEDA by Prosilico outperforms laboratory methods
In 49 study comparisons, ANDROMEDA by Prosilico outperformed laboratory methods in 74 % of cases…
14 November 2022
New article and ANDROMEDA milestone- Successful validation
Validation of predicted conformal intervals for prediction of human clinical pharmacokinetics https://www.biorxiv.org/content/10.1101/2022.11.10.515917v1
3 October 2022
Steps in the right direction!
FDA Modernization Act - The bill defines “nonclinical tests or studies ” as a test…
3 October 2022
New publications
An Analysis of Laboratory Variability and Thresholds for Human in vitro ADME/PK Methods & Prediction…
28 September 2022
Another publication
In vitro to in vivo pharmacokinetic translation guidance https://www.biorxiv.org/content/10.1101/2022.09.26.509470v1
27 September 2022
New publication
Investigation of Molecular Weights and Pharmacokinetic Characteristics of Older and Modern Small Drugs https://www.biorxiv.org/content/10.1101/2022.09.21.508888v1
24 September 2022
New publication
Prediction of Biopharmaceutical Characteristics of PROTACs using the ANDROMEDA by Prosilico Software https://www.biorxiv.org/content/10.1101/2022.09.22.509053v1
14 September 2022
PROSILICO to present at SUP-meeting in Uppsala
https://sup-meeting.se/
